Sheri Lewis
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
SkinHealth Systems Expands SkinStylus MicroSystem to Europe. SkinHealth Systems announced that its SkinStylus® SteriLock® MicroSystem will now be available in European markets. The move expands the company’s footprint beyond North America and could broaden its customer base. The product is a sterilization platform used in dermatology. The news comes as the stock trades near its 52‑week low, but the expansion may support future growth.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Avantor to Report Q3 2026 Earnings on October 28. Avantor has scheduled its third-quarter 2026 earnings release for Wednesday, October 28, 2026. Recent coverage notes that the company led peer groups in research tools and consumables during the second quarter. The stock is currently trading near the lower end of its 52-week range, with analysts maintaining a wide target price spread.
Transaction History
| MMSI | ▲ Buy | Grant | 8,371 | $0 | 9/4/2026 | View on chart |
| SKIN | ▼ Sell | Tax Withholding | 24,904 | $23K | 4/9/2026 | View on chart |
| SKIN | ▲ Buy | Grant | 746,681 | — | 3/20/2026 | View on chart |
| SKIN | ▼ Sell | Tax Withholding | 51,883 | $61K | 3/17/2026 | View on chart |
| SKIN | ▼ Sell | Tax Withholding | 31,296 | $34K | 4/9/2025 | View on chart |
| SKIN | ▲ Buy | Grant | 639,204 | $844K | 3/17/2025 | View on chart |
| AVTR | ▼ Sell | Tax Withholding | 4,556 | $104K | 12/31/2023 | View on chart |
| AVTR | ▼ Sell | Tax Withholding | 1,340 | $33K | 2/25/2023 | View on chart |
| AVTR | ▲ Buy | Grant | 12,185 | $0 | 2/24/2023 | View on chart |
| AVTR | ▼ Sell | Tax Withholding | 970 | $24K | 2/23/2023 | View on chart |
| AVTR | ▼ Sell | Tax Withholding | 6,075 | $128K | 12/31/2022 | View on chart |
| AVTR | ▼ Sell | Tax Withholding | 1,137 | $40K | 2/25/2022 | View on chart |
| AVTR | ▲ Buy | Grant | 9,822 | $0 | 2/23/2022 | View on chart |
| AVTR | ▼ Sell | Tax Withholding | 4,093 | $172K | 12/31/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Merit Medical Systems sets Q3 2026 earnings date
Merit Medical Systems announced it will report its third-quarter 2026 results on October 29, 2026. This upcoming earnings date is the primary catalyst for the stock, as investors await fresh financial updates. The company is currently trading within its 52-week range, with an average analyst target price of $101.45.
Merit Medical Systems sets Q3 2026 earnings date. Merit Medical Systems announced it will report its third-quarter 2026 results on October 29, 2026. This upcoming earnings date is the primary catalyst for the stock, as investors await fresh financial updates. The company is currently trading within its 52-week range, with an average analyst target price of $101.45.